Özlem Türeci

Özlem Türeci is a Turkish-German physician, immunologist and businessperson of Turkish origin. She is a pioneer in cancer immunotherapy. During the 2020 COVID-19 pandemic she shifted her research focus to developing a vaccine against SARS-CoV-2.

About Özlem Türeci in brief

Summary Özlem TüreciÖzlem Türeci is a Turkish-German physician, immunologist and businessperson of Turkish origin. She is a pioneer in cancer immunotherapy. In 2001 she co-founded Ganymed Pharmaceuticals as its chief scientific officer, going on to become its chief executive officer in 2008.

During the 2020 COVID-19 pandemic she shifted her research focus to developing a vaccine against SARS-CoV-2.